Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Different hair growth phases affect how follicles respond to X-rays, and hormones like testosterone and dihydrotestosterone play a key role in baldness; transplanted hair can grow on bald scalp areas.

Different types of hair loss need specific treatments, and while many classification systems exist, each has its flaws; more research is needed to refine these systems and treatments.

Male pattern baldness involves smaller hair follicles, larger oil glands, and other tissue changes, but not major blood supply issues.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Curly hair in certain scalp areas can be an early sign of hair loss.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Inflammation may play a role in causing androgenetic alopecia.

A new treatment for hair loss was tested and most participants saw their hair loss stop within 2-8 weeks, with up to 50% more hair after 4 months, and no side effects.

PCOS can cause excess hair growth, oily skin, hair loss, acne, and dark skin patches.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

An ovarian tumor can cause high male hormones in postmenopausal women.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Female pattern hair loss in Thailand varies by region and demographics, affecting diagnosis and treatment.

Hormonal imbalances can cause hair loss, and understanding them can help develop better treatments.

Microinfusion therapy and testosterone use may cause scalp inflammation, requiring early recognition and treatment.

Homeopathic treatment improved baldness in a young man.

New technologies show promise for safer, more effective hair loss treatments.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Combining scalp acupoint catgut embedding with 5% minoxidil may help treat male pattern baldness.

Certain gene changes and hormone levels are linked to female hair loss.

Trichoscopy is effective for diagnosing hair and scalp disorders without invasive biopsies.

25% of women in North Sudan have traction alopecia, linked to family history and hair treatments, highlighting the need for better hair care awareness.

Hormone replacement therapy may improve hair growth in the frontal hairline of postmenopausal women with hair loss.